Cara Therapeutics (NASDAQ:CARA)

CAPS Rating: 3 out of 5

Caps

How do you think CARA will perform against the market?

Add Stock to CAPS Watchlist

All Players

81 Outperform
6 Underperform
 

All-Star Players

11 Outperform
4 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top CARA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

oncqueen (65.53)
Submitted February 09, 2014

Speculative biotech with good preclinical data on narcotics that do not use the mu receptor but rather the kappa one, making these agents different than currently available narcotics, ideally with less constipation, sedation, and potential for… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CARA VS S&P 500 (SPY)

Fools bullish on CARA are also bullish on:

Fools bearish on CARA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CARA.

Recs

0
Member Avatar Jflagg1991 (37.44) Submitted: 7/19/2018 11:07:23 AM : Underperform Start Price: $19.65 CARA Score: +12.22

Heading down on offering and needs news to stay up

Recs

0
Member Avatar TMFEBCapital (64.71) Submitted: 3/24/2017 3:46:23 PM : Outperform Start Price: $16.78 CARA Score: -16.85

A wave of late stage trial data for its pain drug CR845, plus the potential for a pick-up in M&A, makes this stock attractive.

Recs

0
Member Avatar TMFAnchor (< 20) Submitted: 1/19/2017 12:46:17 PM : Outperform Start Price: $11.71 CARA Score: +20.77

Opioid painkiller that doesn't cross the blood-brain barrier = non-addictive. Huge need for this coming to the forefront of national attention, and huge patient population.

Leaderboard

Find the members with the highest scoring picks in CARA.

Score Leader

slingermoonsine

slingermoonsine (57.57) Score: +288.41

The Score Leader is the player with the highest score across all their picks in CARA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
bonznstonz < 20 3/17/2016 Outperform 3Y $4.76 +237.61% +29.68% +207.92 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. xmas 54.43 6/29/2016 Outperform 5Y $4.86 +230.66% +27.98% +202.68 1 Comment
TheIzzishWizzy 85.16 6/17/2016 Outperform 5Y $5.05 +218.22% +27.38% +190.84 0 Comment
surfco3 80.14 6/16/2016 Outperform 5Y $5.10 +215.10% +27.03% +188.06 0 Comment
jayzmrmn 38.26 7/12/2016 Outperform 3Y $5.18 +210.23% +22.63% +187.60 1 Comment
dundara 90.03 9/6/2016 Outperform 1Y $5.40 +197.59% +20.52% +177.08 0 Comment
MaBrandao 69.93 3/21/2016 Outperform 1Y $5.35 +200.37% +29.16% +171.22 0 Comment
Clopperc < 20 3/7/2016 Outperform 3W $5.37 +199.26% +32.22% +167.03 0 Comment
Playa14 < 20 8/1/2016 Outperform 5Y $6.00 +167.83% +21.35% +146.48 0 Comment
dollarsandcents1 < 20 9/13/2016 Outperform 5Y $6.01 +167.39% +22.68% +144.71 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.16 4/24/2017 Outperform 3W $16.61 0% 0% 0 0 Comment
TrackJimCramer 85.16 3/12/2014 Underperform 3W $20.00 -16.95% +27.13% +44.08 4/24/2017 @ $16.61 0 Comment
TrackJanney 85.05 2/25/2014 Outperform NS $15.27 +5.24% +42.45% -37.21 0 Comment
TrackStifel 91.80 2/25/2014 Outperform NS $15.32 +4.90% +42.45% -37.55 0 Comment

Advertisement